522 Results

People

  1. De Angelis
    De Angelis
  2. Kris
    Kris
  3. Motzer
    Motzer
  4. Livingston
    Livingston
  5. Aghajanian
    Aghajanian
  6. Krown
    Krown
  7. Panageas
    Panageas
  8. Miller
    Miller
  9. Tyson
    Tyson
  10. Vickers
    Vickers

Groups

  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)
  7. Tow Center for Developmental Oncology (TCDO) (51)
  8. Epidemiology and Biostatistics (49)
  9. Population Sciences Research Program (45)
  10. Genitourinary Oncology Service (41)
  1. "headache"
Formats
  1. Journal Article (491)
  2. Review (17)
  3. Research Letter (5)
  4. Conference Paper (3)
  5. Editorial (3)
  6. Book Whole (1)
  7. Guidelines (1)
  8. Miscellaneous (1)
Groups
  1. Department of Medicine (289)
  2. Solid Tumor Oncology Division (180)
  3. Hematologic Malignancies, Division of (104)
  4. Center for Hematologic Malignancies (92)
  5. Survivorship Research (61)
  6. GSK Faculty (55)

More Groups

People
  1. Lisa De Angelis (20)
  2. Mark Kris (20)
  3. Robert Motzer (19)
  4. Philip Livingston (13)
  5. Carol Aghajanian (12)
  6. Katherine Panageas (12)

More People

Years
  1. 2025 (15)
  2. 2024 (34)
  3. 2023 (30)
  4. 2022 (16)
  5. 2021 (18)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (37)
  2. Clinical Cancer Research (23)
  3. Lancet Oncology (20)
  4. Blood (18)
  5. New England Journal of Medicine (17)
  6. Cancer (16)

More Publications

Publishers
  1. Elsevier Inc. (68)
  2. Elsevier Science, Inc. (43)
  3. Springer (42)
  4. American Society of Clinical Oncology (37)
  5. Nature Publishing Group (32)
  6. Oxford University Press (29)

More Publishers

Results (522)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized, double-blind, placebo-controlled phase II study of the efficacy and safety of monotherapy ontuxizumab (MORAb-004) plus best supportive care in patients with chemorefractory metastatic colorectal cancer
    Journal Article

    Grothey, A.; Strosberg, J. R.; Renfro, L. A.; Hurwitz, H. I.; Marshall, J. L.; Safran, H.; Guarino, M. J.; Kim, G. P.; Hecht, J. R.; Weil, S. C.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • A phase II study of radioimmunotherapy with intraventricular (131)I-3F8 for medulloblastoma
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Humm, J. L.; Zanzonico, P. B.; Haque, S.; Dunkel, I. J.; Wolden, S. L.; Donzelli, M.; Goldman, D. A.; Lewis, J. S.; more...
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Central nervous system relapse of rhabdomyosarcoma
    Journal Article

    De, B.; Kinnaman, M. D.; Wexler, L. H.; Kramer, K.; Wolden, S. L.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma
    Journal Article

    Wrzeszczynski, K. O.; Frank, M. O.; Koyama, T.; Rhrissorrakrai, K.; Robine, N.; Utro, F.; Emde, A. K.; Chen, B. J.; Arora, K.; Shah, M.; more...
    Neurology-Genetics (2017)

    Fulltext@MSK | Save
  • Management of latent tuberculosis infection among healthcare workers: 10-year experience at a single center
    Journal Article

    Arguello Perez, E.; Seo, S. K.; Schneider, W. J.; Eisenstein, C.; Brown, A. E.
    Clinical Infectious Diseases (2017)

    Fulltext@MSK | Save
  • A phase 1b dose expansion study of the pan-class I PI3K inhibitor buparlisib (BKM120) plus carboplatin and paclitaxel in PTEN deficient tumors and with dose intensified carboplatin and paclitaxel
    Journal Article

    Smyth, L. M.; Monson, K. R.; Jhaveri, K.; Drilon, A.; Li, B. T.; Abida, W.; Iyer, G.; Gerecitano, J. F.; Gounder, M.; Harding, J. J.; more...
    Investigational New Drugs (2017)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Randomized phase III trial of adjuvant pazopanib versus placebo after nephrectomy in patients with localized or locally advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Haas, N. B.; Donskov, F.; Gross-Goupil, M.; Varlamov, S.; Kopyltsov, E.; Lee, J. L.; Melichar, B.; Rini, B. I.; Choueiri, T. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Pooled analysis safety profile of nivolumab and ipilimumab combination therapy in patients with advanced melanoma
    Journal Article

    Sznol, M.; Ferrucci, P. F.; Hogg, D.; Atkins, M. B.; Wolter, P.; Guidoboni, M.; Lebbé, C.; Kirkwood, J. M.; Schachter, J.; Daniels, G. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas
    Journal Article

    Reiss, S. N.; Yerram, P.; Modelevsky, L.; Grommes, C.
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save